The other signature includes MYO1G that constitutes the minor histocompatibility antigen HA-2 that binds to MHC class I molecules, makes the antigens recognizable by CD8+T cells in tumor cells, and allows the destruction of harmful tumor cells47,48. The gene discussed is CD8A; the disease is neoplasm.